Peter Heerma, Chief Commercial Officer: Travere Therapeutics TVTX Planned sale · Filed 25/10/31

Trade details

Type: Planned sale notice
Stock: Travere Therapeutics TVTX
Person: Peter HeermaChief Commercial Officer
Planned sale date: 25/10/31
Filed: 25/10/31

More to sell after $2,662 in 3 months

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/01~25/11/30

Peter Heerma's recent trades

Peter HeermaChief Commercial Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$525.7K
8,282 sh
$525.7K
Filed 09/17
Traded 09/17
Peter HeermaChief Commercial Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$10.8M
172,717 sh
$10.8M
Filed 09/16
Traded 09/16
Peter HeermaChief Commercial Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$6.7M
102,190 sh
$6.7M
Filed 09/15
Traded 09/15
Peter HeermaChief Commercial Officer
SellTravere Therapeutics
Sell
Travere Therapeutics
TVTX
$101.4K
2,174 sh
$101.4K
Filed 05/06
Traded 05/05
Peter HeermaChief Commercial Officer
Planned saleTravere Therapeutics
Planned sale
Travere Therapeutics
TVTX
$101.4K
2,174 sh
$101.4K
Filed 05/05
Traded 05/05

Peter Heerma, Chief Officer — plans to sell 5,591 sh of Travere Therapeutics TVTX · $195.7K · around 10/31 · 10b5-1 plan | Whalegun